Newcardio Stock Analysis
NewCardio is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of NewCardio stock analysis is to determine its intrinsic value, which is an estimate of what NewCardio is worth, separate from its market price. There are two main types of NewCardio's stock analysis: fundamental analysis and technical analysis.
The NewCardio stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and NewCardio's ongoing operational relationships across important fundamental and technical indicators.
NewCardio |
NewCardio Stock Analysis Notes
The company had not issued any dividends in recent years. NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease , as well as the cardiac safety assessment of drugs under development. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey. EINSTEIN NOAH is traded on NASDAQ Exchange in the United States. To find out more about NewCardio contact Jess MD at 877-332-4324 or learn more at http://www.newcardio.com.NewCardio Quarterly Total Revenue |
|
NewCardio Investment Alerts
NewCardio generated a negative expected return over the last 90 days | |
NewCardio has some characteristics of a very speculative penny stock | |
NewCardio currently holds 6.01 M in liabilities. NewCardio has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about NewCardio's use of debt, we should always consider it together with its cash and equity. | |
The entity reported the previous year's revenue of 257.4 K. Net Loss for the year was (11.5 M) with profit before overhead, payroll, taxes, and interest of 70.81 K. | |
NewCardio currently holds about 13.06 K in cash with (4.56 M) of positive cash flow from operations. | |
NewCardio has a frail financial position based on the latest SEC disclosures |
NewCardio Largest EPS Surprises
Earnings surprises can significantly impact NewCardio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2011-11-15 | 2011-09-30 | -0.08 | -0.07 | 0.01 | 12 | ||
2011-05-12 | 2011-03-31 | -0.09 | -0.08 | 0.01 | 11 | ||
2011-08-15 | 2011-06-30 | -0.07 | -0.03 | 0.04 | 57 |
NewCardio Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 49.72 K.NewCardio Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (4.73) | (4.96) | |
Return On Capital Employed | 11.10 | 11.66 | |
Return On Assets | (4.63) | (4.87) | |
Return On Equity | 4.18 | 2.57 |
Management Efficiency
NewCardio has return on total asset (ROA) of (2.2419) % which means that it has lost $2.2419 on every $100 spent on assets. This is way below average. NewCardio's management efficiency ratios could be used to measure how well NewCardio manages its routine affairs as well as how well it operates its assets and liabilities. The NewCardio's current Return On Capital Employed is estimated to increase to 11.66, while Return On Tangible Assets are projected to decrease to (4.96). As of now, NewCardio's Intangible Assets are increasing as compared to previous years.Last Reported | Projected for Next Year | ||
Book Value Per Share | (0.10) | (0.10) | |
Tangible Book Value Per Share | (0.10) | (0.11) | |
Enterprise Value Over EBITDA | (3.28) | (3.11) | |
Price Book Value Ratio | (8.85) | (8.41) | |
Enterprise Value Multiple | (3.28) | (3.11) | |
Price Fair Value | (8.85) | (8.41) | |
Enterprise Value | 24.1 M | 15.6 M |
NewCardio showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NewCardio, as well as the relationship between them.NewCardio Price Movement Analysis
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. NewCardio middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for NewCardio. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
NewCardio Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NewCardio insiders, such as employees or executives, is commonly permitted as long as it does not rely on NewCardio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NewCardio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
NewCardio Outstanding Bonds
NewCardio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NewCardio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NewCardio bonds can be classified according to their maturity, which is the date when NewCardio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
AerCap Global Aviation Corp BondUS00773HAA59 | View |
About NewCardio Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how NewCardio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NewCardio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NewCardio. By using and applying NewCardio Stock analysis, traders can create a robust methodology for identifying NewCardio entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (39.46) | (41.43) | |
Operating Profit Margin | (42.26) | (40.15) | |
Net Loss | (51.36) | (48.79) | |
Gross Profit Margin | 0.37 | 0.28 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding NewCardio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
Complementary Tools for NewCardio Stock analysis
When running NewCardio's price analysis, check to measure NewCardio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewCardio is operating at the current time. Most of NewCardio's value examination focuses on studying past and present price action to predict the probability of NewCardio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewCardio's price. Additionally, you may evaluate how the addition of NewCardio to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Commodity Directory Find actively traded commodities issued by global exchanges |